ETH269 8 mg (Doxazosin 8 mg)
Pill imprint ETH269 8 mg has been identified as Doxazosin mesylate 8 mg.
Doxazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; raynaud's syndrome and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 8 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- ETH269 8 mg
- Strength:
- 8 mg
- Color:
- Blue
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antiadrenergic agents, peripherally acting
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Ethex Corporation
- National Drug Code (NDC):
- 58177-0269
- Inactive Ingredients:
- hydrated alumina
lactose monohydrate
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
sodium starch glycolate
FD&C Blue No. 2 Aluminium Lake
Note: Inactive ingredients may vary.
More about doxazosin
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 28 Reviews – Add your own review/rating
- Drug class: antiadrenergic agents, peripherally acting
Consumer resources
Other brands: Cardura, Cardura XL
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
